Boston Heart Diagnostics Corporation products

Adiponectin is a measure of the amount of a hormone produced by fat cells that protects against developing heart disease and diabetes.

This test identifies individuals with an increased risk of atrial fibrillation (AF) and stroke. The 4q25 gene locus is on chromosome 4, adjacent to the PITX2 gene, which is a transcription factor required for cardiac development and left-right asymmetry of the heart, and for normal sinus node formation. Two 4q25 variants rs2200733 and rs10033464, found in about 20% of the population, have been associated with a significant 1.4-1.5 fold increased risk of atrial fibrillation (4). This association has been observed in multiple studies, and is especially apparent in subjects over age 60 years.

ALT is an enzyme that has been reported as present in a variety of tissues. The liver is the major source of ALT.

This test identifies individuals who may be at an increased risk of premature CVD which allows for risk reclassification and more aggressive management of modifiable risk factors. The 9p21 gene locus is on chromosome 9. Two 9p21 variants rs10757278 and rs1333049, found in about 40% of the population, have about a 1.5-2.0 fold increased risk of cardiovascular disease versus non-carriers in population studies.

This is a calculated value which indicates the percentage of total LDL-C due to sdLDL-C.